Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ic Pulmonary Fibrosis Report is to understand the market and pipeline status of the drugs around the Idiopathic Pulmonary Fibrosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast To 2023

By Delve Insight
"...... torical and forecasted data of Chronic Obstructive Pulmonary Disease (COPD) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet......"
01-Jan-2017$2750

Klebsiella Pneumoniae Infections-Pipeline Insights, 2017

By Delve Insight
"...... cluding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pa......"
01-Jan-2017$1250

Lung Infections-Pipeline Insights, 2017

By Delve Insight
"...... ND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations ......"
01-Jan-2017$1250

Lung Injury-Pipeline Insights, 2017

By Delve Insight
"...... e I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details......."
01-Jan-2017$1250

Lung Transplantation-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... fection Report is to understand the market and pipeline status of the drugs around the Pneumocystis Infection to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies......"
01-Jan-2017$2000

Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... stand the market and pipeline status of the drugs around the Pneumonia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides th......"
01-Jan-2017$2000

Pulmonary Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... is to understand the market and pipeline status of the drugs around the Pulmonary Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's ......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.